Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays an “All Products” skincare catalog with product listings rather than the previous 403 error screen. The footer revision also advances from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T21:51:12.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, indicating the content is currently inaccessible due to access restrictions, with the site's header and footer still displayed.
    Difference
    19%
    Check dated 2026-09-20T20:49:52.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6. This indicates a general page update without changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-30T22:37:34.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The footer revision tag was updated from v3.6.4 to v3.6.5, indicating a new page build. No study content or data were changed.
    Difference
    0.1%
    Check dated 2026-08-09T13:17:49.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page no longer displays the primary disease label 'Multiple myeloma'. It also removes the 'related topics' header and the 'MedlinePlus Genetics' resource link, reducing context and navigational options for readers.
    Difference
    0.2%
    Check dated 2026-08-02T08:17:21.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, representing a minor deployment update to the page template/renderer. There is no indication of changes to the study data or visible content.
    Difference
    0.1%
    Check dated 2026-07-26T00:17:57.000Z thumbnail image

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.